Intrinsiqs

Is Dianthus Therapeutics, Inc. overvalued?

Dianthus Therapeutics, Inc. (DNTH) — key valuation metrics and fundamentals.

No verdict
Price
$91.81
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$5.17B
Dividend yield
0.0%
Return on equity
-3.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares DNTH's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.